CMC 360

EUIPO EUIPO 2022 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark CMC 360 was filed as Figurative mark on 03/15/2022 at the European Union Intellectual Property Office.
It was registered as a trademark on 09/06/2022. The current status of the mark is "Trademark registered".

Logodesign (Wiener Klassifikation)

#Curved lines or bands (except A 26.11.13) #Three lines

Trademark Details Last update: September 8, 2022

Trademark form Figurative mark
File reference 018671543
Application date March 15, 2022
Publication date May 30, 2022
Entry date September 6, 2022
Expiration date March 15, 2032

Trademark owner

Suite #110, 2 Park Central Drive
01772 Southborough
US

Trademark representatives

South Bank House, Barrow Street, D04TR29 Dublin 4 IE

goods and services

35 Providing business intelligence services in the fields of pharmaceuticals, biotechnology, and life sciences; business consulting services in the field of pharmaceuticals and biopharmaceuticals and related technologies, including clinical development, formulation, evaluation, approval, delivery, commercialization, marketing, and life-cycle management of drugs; business services, namely, formulation of best practices for drug discovery, formulation development, clinical supplies, pharmacology, toxicology, clinical supplies, and clinical development services; regulatory submission management, namely, administrative assistance for others in preparing and filing applications for new pharmaceuticals with governmental regulatory bodies
42 Chemistry, manufacturing and controls (cmc) consulting services in the fields of pharmaceuticals, biotechnology, and life sciences; providing scientific research services in the fields of pharmaceutical design and development, pharmaceutical chemistry, pharmaceutical manufacturing and controls; consulting services regarding research and development, pharmaceutical drug formulation development and quality control in the fields of pharmaceuticals, biotechnology, and life sciences; technical advisory services relating to pharmaceutical products, biotechnology products, and life sciences products; technical consulting in the fields of pharmaceuticals, biotechnology, and life sciences; technical consulting services, namely, evaluating the safety of pharmaceutical products in clinical development or in commercial production; consultation services relating to consumer software in the fields of pharmaceuticals, biotechnology, and life sciences; consulting services for others in the field of design, planning, and implementation project management of clinical development and clinical trials; testing, analysis and evaluation of the goods of others for the purpose of certification; design and development of computer software for database management in the fields of pharmaceuticals, biotechnology and life sciences; pharmaceutical drug development services; toxicology services; pharmaceutical life cycle management services; scientific research consulting in the field of clinical development and clinical trials
45 Regulatory compliance consulting in the fields of pharmaceuticals, biotechnology, and life sciences

ID: 11018671543